# Canagliflozin reduces inflammation and fibrosis biomarkers: a potential mechanism of action for beneficial effects of SGLT2 inhibitors in diabetic kidney disease

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/canagliflozin-reduces-inflammation-and-fibrosis-biomarkers-a-potential-mechanism/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Hiddo J.L. Heerspink,Paul Perco,Skander Mulder,Johannes Leierer,Michael K. Hansen,Andreas Heinzel,Gert Mayer |
| Citations | 458 |
| DOI | 10.1007/s00125-019-4859-4 |
| Fields | Medicine |
| Open Access | true |
| OA Status | hybrid |
| OA URL | https://link.springer.com/content/pdf/10.1007/s00125-019-4859-4.pdf |
| OpenAlex ID | https://openalex.org/W2940024069 |
| PMID | 31001673 |
| Type | article |
| Year | 2019 |

## Paper authors

- [Hiddo J.L. Heerspink](https://scholariq.org/researchers/hiddo-j-l-heerspink/)
- [Gert Mayer](https://scholariq.org/researchers/gert-mayer-2/)

## Paper journal

- [Diabetologia](https://scholariq.org/journals/diabetologia/)

## Paper primary topic

- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)

## Paper topics

- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)
- [Pancreatic function and diabetes](https://scholariq.org/topics/pancreatic-function-and-diabetes/)
- [Chronic Kidney Disease and Diabetes](https://scholariq.org/topics/chronic-kidney-disease-and-diabetes/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.